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Abstract
Purpose To analyze neurovascular coupling in the retina of
untreated primary open-angle glaucoma (POAG) and ocular
hypertension (OHT) patients.
Patients and methods Maximal vessel dilation in response to
flicker light was analyzed with Retinal Vessel Analyzer (RVA)
in temporal superior/inferior arterioles and veins in 51 POAG
patients, 46 OHT and 59 control subjects. RVA parameters
were compared between groups, between contralateral POAG
eyes, and correlated to intraocular pressure, visual field mean
defect and retinal nerve fiber layer thickness.
Results POAG eyes demonstrated generally smaller response
of all vessels to flicker light than the other two groups
(ANOVA p=0.026; mean arterial flicker response in percent
of baseline, averaged superior and inferior was 3.48±2.22 %
for controls , 2.35±2.06% for POAG patients , and 2.97±2.35
% for OHT patients; corresponding values for venules were
3.88±1.98 %, 2.89±1.72 %, 3.45±2.77 %). There was no
difference in flicker response between the eye with more and
less advanced damage in each patient of the POAG group
(ANOVA p=0.79). Correlation of flicker response to intraoc-
ular pressure (IOP) was borderline at best, correlations to the
level of glaucomatous damage were not significant.
Correlation of flicker response of superior and inferior vessels
of the same eye was significant for the arteries (Pearson
r=0.23, p=0.004), as well as venules (r=0.52, p<0.001).
Conclusion General vessel response to flicker light was de-
creased in POAG patients, compared to normal controls and
OHT patients. In contrast to significant correlation between
the two contralateral eyes of the flicker response itself, only its
borderline correlation to IOP was seen. There was no correla-
tion to the level of damage, altogether indicating a systemic
dysregulation phenomenon.
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Introduction
Neurovascular coupling is a local, tissue-specific phenomenon
and represents practically instant vascular reaction of the tissue
to elevated functional activity [1, 2]. It has been explored in the
field of neurology, and in the last several years it has become
subject of interest in glaucoma as well [3–6]. Blood flow
alterations, and in particular the variability of perfusion of optic
nerve head, is believed to be one of the major risk factors for
glaucoma [7]. Capability of the vascular system to respond to
changing metabolic needs is essential for the functional and
morphological integrity of the neural tissue. Analysis of vessel
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response to challenge, rather than capturing a steady-state
baseline flow, is essential for understanding the role of perfu-
sion in glaucomatous damage, in particular because ischemia-
reperfusion damage has been implicated in the pathogenesis of
glaucoma [8]. The retina is an optically easily accessible ocular
neural tissue, which makes the use of the Retinal Vessel
Analyzer (RVA; IMEDOS GmbH, Jena, Germany) suitable
for this purpose [9, 10]. Data on reproducibility of this device
[11, 12], as well as protocols for specific use of the device, have
been published recently [13]. Several studies have indicated a
disturbance of ocular neurovascular coupling in glaucoma,
using various techniques [4–6]. For this reason, we initiated a
prospective project-study on retinal vessel response to flicker-
ing light in patients with open-angle glaucoma and ocular
hypertensives. Parts of the project's database were used to
analyze the dynamics of the vessel response to repeated flicker
stimulation, and results were recently published [14]. Based on
the findings that some subjects may demonstrate alterations in
this regard [15], the focus of this partial analysis was on differ-
ences in diameter vessel behaviour during the three entire
flicker periods (“area under the curve” of vessel diameter) in
one retinal site. Herewith, we report final results of the cross-
sectional analysis of neurovascular coupling in untreated
patients with glaucoma and ocular hypertension, with particular
emphasis on the association between the level of glaucomatous
damage and a maximal flicker-induced dilatory capacity of
retinal vessels. Comparisons of maximal vessel dilation were
performed in various retinal sites (superior and inferior), as well
as between the two contralateral eyes in glaucoma patients.
Patients and methods
Subjects and methods
Local ethical committee approved the study, and after the study
registration at ClinicalTrials.gov, the recruitment was con-
ducted beginning in 2007 and lasted for 3 years. An informed
consent was obtained from each study subject, following the
tenets of the Declaration of Helsinki. Patients with primary
open angle glaucoma (POAG) and ocular hypertension (OHT)
were consecutively recruited from the glaucoma consultations
at the Ophthalmology Department of the University Hospital
Basel. As subjects of the cross-sectional analysis per protocol
needed to be therapy-free, newly diagnosed and untreated
POAG and OHT patients meeting study criteria underwent
study examinations, patients on intraocular pressure (IOP)-
lowering therapy were first subjected to a 4-week wash-out
phase. Healthy controls were recruited through ads in local
newspapers. A detailed medical and ophthalmic history was
recorded. As detailed previously [14], ophthalmological
examinations included the IOP readings with Goldmann
applanation tonometry at 8 h, 11 h and 16 h. POAG was
diagnosed based on glaucomatous optic disc cupping (in
particular: thinning of the inferior and/or superior rim,
cup-to-disc ratio asymmetry of > 0.2 not due to optic disc
size asymmetry), and based on matching glaucomatous
visual field defects (specifically, a cluster of three or more
test points with > 5 dB or two points with > 10 dB
sensitivity reduction compared to age-eccentricity corrected
normal value) [16]. Importantly, untreated IOP was neither
exclusion nor inclusion criterion for POAG diagnosis; based
on this, patients from both the “high tension” and “normal
tension” sides of the IOP spectrum in POAG were included.
In contrast, narrow angle glaucoma, as well as patients with
any form of secondary glaucomas, including pigment dis-
persion and pseudoexfoliation, were excluded. For ocular
hypertensives, at least two daily readings of untreated IOP
in the run-up to the study had to be equal or above
21 mmHg, in absence of disc or visual field damage. All
participants with diabetes mellitus, untreated or unstable
essential hypertension, untreated or unstable hypercholester-
olemia, drug or alcohol abuse, history of eye surgery except
uneventful cataract surgery, high ametropia (spherical equiv-
alent<−5 diopters or>+3 diopters), astigmatism above 2
diopters, and significant cataract were excluded from the
study. Smoking was an exclusion criterion [17]. In the
POAG group, both eyes were analyzed. In the OHT group
an eye with the higher mean diurnal IOP was selected, and
in healthy controls, one randomly selected eye per subject
entered the analysis.
For retinal vascular examinations, we used RVA
(IMEDOS GmbH, Jena, Germany). Details on the device
and its flicker-light related application have been published
previously [9, 10, 13–15, 18]. Briefly, an essential part of of
the RVA device is the fundus camera (FF450, Zeiss Jena,
Germany), which allows the examination and recordings of
the ocular fundus. It incorporates the illumination and the
observation optical pathway. After being reflected from the
retina, the light is delivered through the observation path-
way to the observation ocular and to the charge-coupled
device (CCD) chip of the video camera simultaneously.
The measuring principle of the RVA is as follows: inside
the walls of the retinal blood vessels there is a column of red
blood cells, separated from the walls by the plasma edge
stream. Red blood cells absorb one part of the light. RVA
measures the diameter of the column of the red blood cells.
The fundus camera was adjusted to the dilated pupil
and a clear fundus image with good contrast and no
reflections was obtained on the monitor. There are 25
captured full video frames per second. Flicker stimula-
tion is achieved by the optoelectronic shutter with
12.5 Hz frequency, which darkens each second frame,
leaving every other one normally exposed. These still
pictures were analyzed by the RVA software. RVA pro-
duces one vessel width measurement, expressed in units
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of measurement (UM), for each segment length of 12.5
UM. In an emmetropic person, 1 UM=1 micrometer.
Four major temporal vessel segments were selected for
our measurements: one vein and one artery, one of each
inferior and superior. Vascular geometry governed the exact
location of the measurement (Fig. 1). After an initial base-
line still illumination during 50 seconds, the first of three
flicker cycles, each lasting 20 seconds, was conducted; after
each flicker cycle, there was a period of 80 seconds still
illumination in between. There was no dark adaptation prior
to examination, and the light exposure during the examina-
tion was high, so the examined eye was constantly under
photopic conditions. The length of the chosen vessel segment
was also determined by the vessel geometry, but was in all
cases between 500 and 750 micrometers, corresponding to 40
to 60 measuring points (the device is set to obtain one trans-
verse diameter reading, based on vessel image brightness
profile, at each 12.5micrometer vessel length). Image stability
of chosen vessel location is ensured by the eye/image-tracking
software, which is in turn based on the vessel branching
geometry.
Visual field was measured by automatic perimetry with
Octopus (Interzeag, Schlieren, Switzerland), and the visual
field mean defect (MD) was entered in the analysis [19]. The
average peripapillary retinal nerve fiber layer thickness
(RNFLT) was measured by optical coherence tomography
(Stratus OCT, Carl Zeiss Meditec, Germany), as a measure
of morphologic glaucomatous damage. Details on this de-
vice and its previous use in glaucoma have been published
elsewhere [18, 20, 21]. Fast RNFL thickness protocol was
applied, scans with signal strength (as a measure of scan
quality) of less than 6/10 were repeated and if no higher
value was possible, rejected.
Experimental setup and statistics
Since OCT scanning and retinal blood flow measurements
(with RVA) required pupil dilatation, they were performed
on the same day after the visual field testing. This was the
second visual field (VF) testing and its result entered the
analysis (first testing was performed in the recruitment
phase for selection purposes). Pupil was dilated with tropi-
camide drops in all subjects. The operator was masked to the
status of the participants as well as to the visual field testing
results during OCT and RVA measurements . After the OCT
measurement, a short break (10–20 minutes) followed to
gain stable hemodynamic conditions, which was confirmed
by oscillometric blood pressure and pulse rate measure-
ments comparable to initial readings. All RVA measure-
ments were conducted by the same experienced researcher
(AK). Recordings were taken in two steps for each eye,
separately for the superior and inferior branches, in a ran-
dom order. Between each step, a time window of at least
20–30 minutes was left in place for recovery. In POAG
patients, both eyes were measured. A maximal vessel dila-
tion after flicker light exposure, calculated as the mean
vessel diameter during the last 2 seconds of each 20-
second flicker period, and then averaged for all three flicker
periods, was the measure of vessel response. Vessel re-
sponse was therefore expressed in micrometers, as a differ-
ence between maximal dilation and the baseline diameter
values, and also in relative numbers—dilation in percent to
baseline. IOP was measured with the Goldmann applanation
tonometry at the end, and this value (not the values recorded
during recruitment) is reported in the Results section.
One-way analysis of variance was used for descriptive
purposes and three way ANOVAmodels were used to analyze
differences between groups. A P value of less than 0.05 was
considered significant. One eye of healthy controls was ran-
domly chosen, while in glaucoma patients, the eye with the
more advanced damage (measured by OCT RNFLT, VF MD
or both) was chosen, and in ocular hypertensives, the eye with
the higher IOP was selected. We also examined the fellow eye
in glaucoma patients and compared the two eyes in statistical
models for dependent samples (repeated or dependent-
samples ANOVA). Furthermore, Pearsons' correlation analy-
sis was used to analyze association between glaucoma damage
parameters (visual field MD and OCT RNFLT), and RVA
parameters: average baseline vessel diameter and vessel re-
sponse to flickering light. Correlations were calculated within
Fig. 1 Typical Retinal Vessel Analyzer (RVA) measurement locations
on a fundus photo of a control subject: temporal inferior artery and
vein, and temporal superior artery and vein
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the POAG group using one (worse) eye per patient. Moreover,
correlations of the same parameters, but using their interocular
differences (delta), were also performed.
The only available data for the power calculations are
the results of the mentioned study assessing the retinal
vessel response to flicker light in glaucoma patients [4].
However, in this study, a different flicker setting was
used. Without appropriate pilot study results, the mini-
mal sample size was set arbitrarily, based on the fol-
lowing criteria: in the present study, four parameters
were of primary interest, superior and inferior temporal
retinal artery and vein flicker response (four parame-
ters); and four were of secondary interest: visual field
mean defect, OCT RNFL mean thickness, mean blood
pressure and IOP. Taking ten subjects per parameter of
primary interest sets the lower limit of required sample
size at 40 participants in each of the study groups. In
order to have a safety margin, because poor fixators and
patients with poor RVA data quality were to be exclud-
ed, we set the sample size at n=50 per group. The
recruitment was continued in parallel in all groups until
the slowest recruiting one reached this threshold. OHT
patients meeting the study criteria turned out to be a
recruitment challenge, and the recruitment was stopped
as soon as this last group reached n=50. All subjects
with poor fixation (RVA) and unreliable / poorly repro-
ducible visual field and OCT testing were excluded.
Results
Parameters of interest are presented in Table 1. There was no
significant statistical difference between the three groups
either in age (ANOVA p=0.41) or in gender distribution
(chi-square test contingency table 3x2, p=0.36).
The following medications were used from the following
number of patients in the control/POAG/OHT group, re-
spectively (some patients had more than one of the men-
tioned medications): no systemic therapy 37/27/28, statins
5/8/8, beta-blockers 3/3/5, diuretics 1/5/3, angiotensin con-
verting enzyme blockers 4/7/5, calcium channel blockers
0/2/0, magnesium 4/5/4, aspirin 2/5/8, antidepressants
2/4/5, hormonal substitution therapy 5/0/1. Chi-square test,
analyzing the number of therapy free patients vs. patients
with therapy, was not significant between each pair of
groups (smallest p>0.1).
Differences across groups in systolic (ANOVA p=0.067)
and diastolic blood pressure (ANOVA p=0.059) were bor-
derline significant, with OHT patients having the highest
and POAG patients the lowest readings.
Untreated IOP, OCT RNFL and visual field damage were
all eo ipso highly statistically different across groups, with
highest IOP in the OHT group and lowest in controls, with
thinnest OCT RNFL/highest VF MD in POAG patients and
thickest OCT RNFL / lowest MD VF in controls. .
Comparisons between three groups
Randomly selected eyes in the control group, the eye with
more pronounced damage (worse eye) in the POAG group
and the eye with higher IOP in the OHT group, one eye per
subject in all groups, entered this analysis.
Regarding baseline vessel diameter, the three-way
ANOVA model, with groups as the first factor, arter-
ies/veins as the second and inferior/superior vessels as
the third factor for the baseline diameter demonstrated
only the arteries-to-veins difference as highly significant
(p<0.001), all other factors and interactions had
p-values p>0.05.
In the analog model for the average absolute flicker
response, the difference between the groups was significant
(p=0.014), and differences between arteries and veins, and
superior versus inferior were both highly significant
(p<0.001).
Correlation between the baseline vessel caliber in
micrometers and the absolute flicker response in micro-
meters was absent in both arteries and veins, both
superior and inferior (all four p values between 0.051
and 0.39), indicating that amplitude of dilation did not
depend on the baseline vessel diameter. Nevertheless,
the absolute flicker response was standardized for the
vessel diameter and the relative response in percent
(%)-to-baseline analyzed with the analogue three-way
ANOVA model. The difference between the groups
was again significant (p=0.026), as was the difference
between arteries and veins (p=0.01), as well as the
difference between superior versus inferior, which was
highly significant (p<0.001). The post-hoc analysis
with the LSD (least significance differences) test
revealed a significant difference in relative flicker re-
sponse between the POAG and control eyes (p=0.007),
whereas no significant difference was present either
between the OHT and POAG eyes (p=0.15) or between
the OHT and control eyes (p=0.24). Results are graph-
ically presented in Fig. 2. In order to control for con-
founders, age and IOP readings were included in the
above model as covariates—results remained essentially
the same (difference between groups p=0.033; LSD test
between POAG and controls p=0.005, between the
OHT and POAG eyes p=0.069, between OHT and
control eyes p=0.38). Moreover, after an exclusion of
study subjects under systemic beta-blockers therapy
(which, although equally distributed across three groups
(3/3/5), could have influenced the results, no relevant
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change in result pattern was observed; the same was
the case with ACE-blockers (data not shown).
Comparisons between the “worse” and the “better” eye
in each patient in the POAG group
The eye with more advanced damage from each POAG
patient constituted one group, and the fellow eye, the
other group. There was no statistical difference in relative
flicker response between the two groups (repeated
ANOVA p=0.79), irrespective of the vessel nature (inter-
action with arteries/veins not significant) and of position
(interaction inferior versus superior not significant). With
IOP as a covariate in the analysis above, results were
similar (repeated ANOVA p=0.69).
Same results were observed also for baseline vessel
diameters and absolute flicker response (all p values>0.1).
Association between the RVAvessel parameters and the IOP
Apart from group comparison of RVA vessel parameters
between the controls and the OHT group, the analysis of
association between the RVA vessel parameters and the IOP
was also done by merging the control and the OHT group
together and performing Pearson correlation analysis. Of all
investigated RVA parameters, baseline diameter and relative
flicker response in arteries and veins separately (values from
superior and inferior regions were averaged for this analysis),
the relative flicker responses correlated with borderline sig-
nificance with the IOP: mean relative flicker response of
Table 1 Parameters of interest±standard deviation: sample size of
each group, gender distribution, systolic and diastolic blood pressure
(BP), intraocular pressure (IOP); Retinal Vessel Analyzer (RVA)
parameters: baseline vessel diameter (average of first 50 seconds re-
cording under still illumination), average diameter of the last two
seconds of three flicker periods minus the baseline diameter as the
absolute flicker response, relative flicker response as the absolute
response standardized with baseline diameter. All corresponding units
are reported in brackets
Parameter Healthy controls POAG OHT
worse eye better eye
Sample size (n = ) 59 51 46
Gender (m/f) 32/27 21/30 24/22
Age (years) 59±9 60±10 61±9
Systolic BP (mmHg) 140.9±21.8 134.4±19.5 147.0±25.7
Diastolic BP (mmHg) 81.0±12.3 75.6±11.1 81.7±12.7
IOP (mmHg) 13.6±2.8 17.1±4.5 15.8±4.6 21.5±3.9
Baseline vessel diameter (micrometers)
Inferior artery 113.8±15.6 109.0±12.7 112. 0±12.5 111.8±14.9
Superior artery 112.0±12.4 110.7±10.8 111.8±14.3 110.8±14.4
Inferior vein 146.1±19.7 143.3±18.6 143.4±15.6 142.1±22.8
Superior vein 139.8±19.1 136.9±17.9 135.4±21.3 141.1±14.4
Average absolute flicker response
(last two seconds peak – baseline; in micrometers)
Inferior artery 4.4±3.3 2.9±2.8 2.9±4.2 4.2±4.9
Superior artery 3.2±2.9 2.2±2.7 1.7±3.4 2.2±2.3
Inferior vein 6.2±3.3 4.7±3.1 5.0±3.4 5.7±4.5
Superior vein 5.0±3.2 3.3±2.8 3.1±3.4 3.8±3.8
Average relative flicker response (last two seconds peak –
baseline / baseline, × 100 %; in %)
Inferior artery 4.0±3.0 2.7±2.7 2.8±3.8 3.9±4.4
Superior artery 2.9±2.7 2.0±2.5 1.6±3.0 2.0±2.1
Inferior vein 4.2±2.2 3.4±2.2 3.5±2.3 4.1±3.5
Superior vein 3.6±2.3 2.4±2.0 2.4±2.6 2.8±2.7
OCT RNFL (micrometers) 100.1±11.1 75.7±15.9 86.6±14.5 94.2±11.3
Visual field MD (dB) 0.79±1.6 3.4±3.2 1.4±2.1 0.29±1.44
MD mean defect, OHT ocular hypertension, POAG primary open-angle glaucoma, RNFT retinal nerve fiber thickness
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arterioles (Pearson r=−0.19, p=0.048) and of venules
(Pearson r=−0.20, p=0.042). After Holms correction for mul-
tiple comparisons, this correlation was deemed not significant.
Association between the RVA vessel parameters
and the glaucomatous damage in the POAG group
separately
Of all investigated RVA parameters, baseline diameter and
relative flicker response (arteries and veins were analyzed sep-
arately; values from superior and inferior regions were averaged
for this analysis), only baseline arterial diameter correlated
significantly with an average OCT RNFL thickness (Pearson
r=0.35, p=0.02; after Holms correction for multiple compar-
isons, this correlation was deemed not significant). None of the
RVA parameters correlated with the visual field damage.
Here, differences (delta) in each patient between eyes with
more and less advanced glaucomatous damage were also
subject of analysis.Whereas a strong correlation was observed
between delta MD versus delta OCT RNFL (Pearson r=0.69,
p<0.001), indicating strong function-structure relationship
between the two eyes of the same patient in this data set, no
correlation was observed between deltas of RVA parameters
on one side and deltas of glaucomatous damage (visual field
MD and OCT RNFL) on the other side.
Correlation between mean relative flicker responses,
interocular in the POAG group and intraocular (superior
versus inferior) in all groups merged together
Relative arterial flicker response (values from superior and
inferior region were averaged for this analysis) correlated
between the eyes in the POAG group, Pearson r=0.3, p=
0.04; results for relative venous flicker response were
Pearson r=0.54, p<0.001.
Relative arterial flicker response correlated signifi-
cantly between the superior and inferior region in all
three groups pooled together, one eye per subject
(Pearson r=0.23, p=0.004; Fig. 3). Relative venous
flicker response demonstrated similar pattern (Pearson
r=0.52, p<0.001; Fig. 4). Correlation of venous re-
sponse was significantly stronger than that of arteries
(two-way correlation coefficient comparison test,
p=0.037).
Discussion
The present study demonstrated a strongly reduced reti-
nal vessel response in POAG patients compared to
healthy control eyes. Vascular response of OHT eyes
differed significantly neither to control nor to POAG
eyes. Comparison between eyes with more advanced
and less advanced glaucomatous damage revealed differ-
ences neither in terms of baseline vessel diameter nor
vessel response to flicker light. There was no correlation
between the vessel responses and either measure of glau-
comatous damage, VF MD or OCT RNFLT. This was
also the case when interocular differences in glaucoma
damage were correlated to interocular differences in ves-
sel response. In contrast, a weak (arterioles) to moderate
(venules) correlation of vessel response itself was present
between the two contralateral eyes, and also within the
same eye superiorly and inferiorly, indicating common
vascular regulatory mechanisms.
An obvious question arising from the cross-sectional
design of the study is whether the observed reduced vessel
response in POAG eyes could merely be a consequence of
the glaucomatous damage. Due to tissue loss, activation
through flickering light would require smaller perfusion
increment, which would hence result in weaker vessel
response. There are a number of arguments that challenge
such explanation. The reported neurovascular coupling
was recorded in the retina and retinal circulation, and
not in the presumed primary site of glaucomatous
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damage—in the optic nerve head. The retina, and in
particular the retinal ganglion cells which are supplied
by retinal circulation, are indeed damaged in glaucoma—
but in relative terms not as much as the neural tissue of
optic nerve head. Thus, an explanation for almost one
third smaller retinal vessel response in POAG compared
to control eyes should be sought elsewhere. Moreover, if
the retinal tissue loss carried significant weight in these
terms, one would expect smaller baseline retinal vessel
calibers. This was not the case. There is one further
argument, and that is the missing correlation between the
vessel response and the level of glaucomatous damage. If
reduced vessel response was merely a consequence of
tissue loss, one would expect such a correlation—and
there was none. Still, probably the most important argu-
ment against the “less tissue, less blood flow demand”
explanation is the observation of lacking vascular differ-
ences between eyes with more and eyes with less ad-
vanced glaucomatous damage. Again, if less tissue leads to
less flow demand, more affected eyes would have to demon-
strate differences compared to to the more preserved ones.
This was not the case. POAG patients in our study were
predominantly in an early damage stage of glaucoma, and this
fact could at least in part explain a weak or missing correla-
tion. Of note, Garhofer et al. reported on reduced retinal
vascular response already in early stages of glaucoma, under-
scoring that we are not dealing merely with a consequence of
the glaucomatous damage [4].
So, if not the consequence, can this vascular dysregula-
tion be seen as a cause of the damage? Considering just the
same arguments as above, the missing correlation between
the level of glaucomatous damage and the retinal vessel
response, it is conceivable that disturbed retinal neurovas-
cular coupling is not a major direct contributor to the
damage. Disturbances in retinal circulation are unlikely to
directly cause the glaucomatous damage. Results of other
studies confirm a weak or missing correlation between the
glaucomatous damage and vascular parameters in the retina
[22]. However, a similar finding was reported for the optic
nerve head itself [5], indicating that disturbed neurovascular
coupling can be regarded as a strong indicator of underlying
vascular dysregulation, rather than a direct damage causing
mechanism. The observation of interocular and intraocular
correlations of vessel responses across all groups, as well as
the observation that both eyes of POAG patients show com-
parable levels of vessel response reduction, might be
explained by a possible systemic character of vascular distur-
bance. This vascular dysregulationmay in turn, in concert with
other risk factors, contribute to the glaucomatous damage.
What, indeed, are possible causes of reduced neurovas-
cular coupling in the retina of glaucoma patients? We ana-
lyzed IOP as a factor influencing retinal vessel response.
Previous studies demonstrated a flicker response indepen-
dence on short term IOP elevation [23–25]. In contrast to the
mentioned studies, we focused on the association with long
term spontaneously elevated IOP. Our results were border-
line. Given the very weak correlations between the IOP and
vessel responses, and also a lack of difference in vessel
responses between the OHT group and control eyes, it
seems that the contribution of long term higher IOP to the
vessel response disturbance would be modest at best, and
the explanation likely lies elsewhere. THe following con-
siderations are merely an attempt to interpret the study
findings and put them into perspective based on the current
literature and on the observations made in the study.
Activation of neuronal tissue leads to complex gliovascular
dialogue, with nitric-oxide as the effective vasodilator [2,
26, 27]. In the retina itself, it is not clear whether a general
release of nitric-oxide during flicker light exposure directly
affects all the neighbouring vessels by diffusing across their
walls, including those with calibers >70–80 micrometers,
which are relevant for RVA measurements; or, alternatively,
the first major effect takes place in smaller vessels and
precapillary sphincters, where gliovascular contact is mostly
realized through astrocytic processes, forming a functional
microvascular unit consisting of endothelial and smooth
muscle cells and their associated perivascular astrocytes,
like elsewhere in brain [28]. The next question is how the
information on vessel dilation is communicated from these
smaller resistance vessels to the larger RVA relevant vessels.
Due to their intercellular gap-junctions, endothelial cells can
be seen as a functional syncytium, conveying information
along the vascular tree [29]. Alternatively, or perhaps as an
addition to the above mechanisms, once small resistance
vessels are opened, the blood column starts moving faster
through all the vessels. Larger arterioles and venules sense
this motion by their endothelial cells through shear-stress
signalling mechanisms, and dilate. Flow-mediated dilation
is a well known regulatory mechanism in large vessels, but
together with endothelium-independent myogenic mecha-
nisms, it also plays a very important role in arterioles
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baseline) in the inferior versus superior temporal region (Pearson
r=0.52, p<0.001)
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(40–80 microns) and venules (80–120 microns) as well [30,
31]. The flow mediated regulatory mechanism can be dis-
turbed, and indeed, the study by Fadini et al. reported on
reduced flow-mediated dilation in the brachial artery of
POAG patients [32].
Moreover, our observation that several POAG patients
demonstrated an arteriolar only or venous only dilation
would further support such an explanation. Arterioles and
venules seem to be regulated independently of each other.
Interocular and intraocular correlations of venule responses
are stronger than those of arterioles. Apart from more stable
RVA signal from venules, one possible explanation lies in
different regulatory mechanisms compared to arterioles,
putting in former an emphasis on endothelial shear-stress
flow regulatory mechanisms, and making it due to lower
intraluminal pressures less dependent on rather local,
segment-based, myogenic regulatory components [31, 33].
At present, it is not clear what specific molecular mech-
anism or mechanisms could lead to vascular dysregulation,
which also includes disturbance of neurovascular coupling
in the retina. Possible culprits are the endothelin [34] or the
nitric-oxide systems [35].
In contrast to baseline vessel caliber, the vessel response
both in relative and in absolute numbers was in the superior
retinal half in all groups and in all vessels smaller than
inferiorly. As different levels of retinal adaptation are un-
likely because RVA recordings were taken in two regions in
random order, this fairly robust finding still remains without
explanation, apart perhaps from interpreting the ISNT rule
[36] in terms of less tissue, less perfusion.
There are several downsides of the present study.
Although retinal circulation is highly important for the ret-
inal ganglion cells and their axons, as mentioned earlier,
prelaminar optic nerve head tissue and not the retina is the
presumed primary site of glaucoma damage, and informa-
tion on retinal vessels relates indirectly to glaucoma. Our
results are further limited by the fact that RVA measures
only the alteration of the vessel diameter, but not the blood
flow velocity inside the vessel. In addition, the RVA ana-
lyzes the thickness of the erythrocytes column, and not the
whole wall-to-wall vessel diameter. Moreover, we only
measured the vessel diameter in a chosen segment and not
on the whole visible vessel tree. This downside was partly
mitigated by obtaining sample information from both the
superior and inferior part of the eye. The RNFL thickness
might have in itself affected RVA measurements, because
vessels are embedded in it. Indeed, baseline vessel diameter
did correlate with the RNFL thickness, but relative flicker
response did not. The next drawback of the study is that we
used only the last two seconds of the flicker-induced diam-
eter change averaged over all three flicker periods in our
statistical analysis, corresponding to the maximal dilation.
Although arbitrarily taken, this parameter could indeed be
representative of a maximal dilatory capacity of retinal
vessels in this type of examination in glaucoma patients, a
point of view shared by other research groups as well [4].
Lastly, based on the untreated IOP (as mentioned earlier,
IOP was not an exclusion/inclusion criterion for the POAG
group, they were consecutively recruited in our referral
institution specialized in vascular ocular disorders), it is
likely that our cohort of POAG patients contains larger
percentage of the so-called “normal”-tension glaucoma
patients, giving more weight to pathogenetic mechanisms
other than IOP, and thus providing only limited significance
of results for the general POAG population.
There is a considerable overlap of the flicker response
between the groups, which might be a disadvantage with
respect to result interpretation in individual patient. In compar-
ison to the mean relative flicker response of POAG eyes, 40 (of
59) control eyes demonstrated stronger arterial vasodilatory
response, 43 of 59 stronger venous response; the best “cut-
off” was achieved when an average arterial-venous flicker
response was analyzed—46 of 59 control eyes demonstrated
a response stronger than the mean response of the POAG eyes.
In summary, neurovascular coupling is disturbed in the
retina of topically untreated POAG patients. This feature
seems to be independent of IOP; it is not merely a conse-
quence of glaucomatous damage, and is likely a strong indi-
cator of an underlying vascular dysregulation that contributes
to the damage. It will take longitudinal studies to evaluate the
predictive value of retinal neurovascular coupling for the
development of glaucomatous damage, and also to assess
the value of neurovascular coupling as a follow-up parameter
for the success of perfusion supporting glaucoma therapy.
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